These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 26564077)

  • 1. Von Hippel-Lindau disease.
    Chittiboina P; Lonser RR
    Handb Clin Neurol; 2015; 132():139-56. PubMed ID: 26564077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
    Richard S; Martin S; David P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Hippel-Lindau syndrome. A pleomorphic condition.
    Friedrich CA
    Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Von Hippel-Lindau disease: recent advances in genetics and clinical management].
    Richard S; Parker F; Aghakhani N; Allegre G; Portier F; David P; Marsot-Dupuch K
    J Neuroradiol; 2005 Jun; 32(3):157-67. PubMed ID: 16134297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease.
    Ding X; Zhang C; Frerich JM; Germanwala A; Yang C; Lonser RR; Mao Y; Zhuang Z; Zhang M
    J Neurosurg; 2014 Aug; 121(2):384-386. PubMed ID: 24678776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease.
    Richard S; David P; Marsot-Dupuch K; Giraud S; Béroud C; Resche F
    Neurosurg Rev; 2000 Mar; 23(1):1-22; discussion 23-4. PubMed ID: 10809480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
    Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic manifestations of von Hippel-Lindau disease.
    Butman JA; Linehan WM; Lonser RR
    JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
    Richard S; Gardie B; Couvé S; Gad S
    Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
    Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
    J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
    Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review.
    Ganeshan D; Menias CO; Pickhardt PJ; Sandrasegaran K; Lubner MG; Ramalingam P; Bhalla S
    Radiographics; 2018; 38(3):849-866. PubMed ID: 29601266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
    Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
    Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
    Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
    BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.
    Park S; Chan CC
    Histol Histopathol; 2012 Aug; 27(8):975-84. PubMed ID: 22763871
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.